The US-Iran peace deal is finally about to happen. There is a high probability that global markets will see a relief rally, a part of which...

Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

If the US-Iran ceasefire holds, the markets may see some recovery. The movement of crude oil prices and its impact on the markets supports ...

If the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...

Nifty closed marginally higher last week, driven by IT and energy stocks, as markets brace for key events. Technical analysts suggest Nifty...

Bernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...

Indian companies significantly boosted overseas investments in April. Direct investments surged to $3.37 billion, more than doubling from M...

Given the latest news flow from the Gulf region, the probability is high that we might once again see the bulls attempting a comeback. As u...

Benchmark indices closed marginally higher on Wednesday, led by gains in banking and auto shares, while IT and FMCG stocks capped advances....

Nifty 50 closed higher for a second straight session, driven by banking, metal and pharma stocks despite IT weakness. Analysts see 23,800 a...

Wealthy investors are making significant moves, pouring over $1 billion into ten select stocks. This concentrated buying occurs even as the...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

Parag Parikh Flexi Cap Fund boosted its holdings in ITC, TCS, and HDFC Bank during April. The fund also increased its stake in fourteen oth...

Over a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...

As far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...

In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...

Shares of Cohance Lifesciences surged 20% on Monday after the appointment of former Cipla CEO Umang Vohra as its new Executive Chairman and...